TSTD CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. TSTD Gen Silencer sind erhältlich als TSTD CRISPR/Cas9 Knockout Plasmide und TSTD Double Nickase Plasmide. TSTD CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
TSTD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TSTD1 CRISPR/Cas9 KO Plasmid (h) | sc-418783 | h | Gene Knockout | GFP | 0 | ||
TSTD1 HDR Plasmid (h) | sc-418783-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TSTD1 Double Nickase Plasmid (h) | sc-418783-NIC | h | Gene Knockout | Puromycin | 0 | ||
TSTD1 Double Nickase Plasmid (h2) | sc-418783-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TSTD2 CRISPR/Cas9 KO Plasmid (h) | sc-414791 | h | Gene Knockout | GFP | 0 | ||
TSTD2 HDR Plasmid (h) | sc-414791-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TSTD2 Double Nickase Plasmid (h) | sc-414791-NIC | h | Gene Knockout | Puromycin | 0 | ||
TSTD2 Double Nickase Plasmid (h2) | sc-414791-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TSTD2 CRISPR/Cas9 KO Plasmid (m) | sc-435459 | m | Gene Knockout | GFP | 0 | ||
TSTD2 HDR Plasmid (m) | sc-435459-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TSTD2 Double Nickase Plasmid (m) | sc-435459-NIC | m | Gene Knockout | Puromycin | 0 | ||
TSTD2 Double Nickase Plasmid (m2) | sc-435459-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TSTD3 CRISPR/Cas9 KO Plasmid (h) | sc-418663 | h | Gene Knockout | GFP | 0 | ||
TSTD3 HDR Plasmid (h) | sc-418663-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TSTD3 Double Nickase Plasmid (h) | sc-418663-NIC | h | Gene Knockout | Puromycin | 0 | ||
TSTD3 Double Nickase Plasmid (h2) | sc-418663-NIC-2 | h | Gene Knockout | Puromycin | 0 |
TSTD CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TSTD1 CRISPR Activation Plasmid (h) | sc-418783-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD1 CRISPR Activation Plasmid (h2) | sc-418783-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD1 Lentiviral Activation Particles (h) | sc-418783-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD1 Lentiviral Activation Particles (h2) | sc-418783-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 CRISPR Activation Plasmid (h) | sc-414791-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 CRISPR Activation Plasmid (h2) | sc-414791-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 Lentiviral Activation Particles (h) | sc-414791-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 Lentiviral Activation Particles (h2) | sc-414791-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 CRISPR Activation Plasmid (m) | sc-435459-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 CRISPR Activation Plasmid (m2) | sc-435459-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 Lentiviral Activation Particles (m) | sc-435459-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD2 Lentiviral Activation Particles (m2) | sc-435459-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD3 CRISPR Activation Plasmid (h) | sc-418663-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD3 CRISPR Activation Plasmid (h2) | sc-418663-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD3 Lentiviral Activation Particles (h) | sc-418663-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TSTD3 Lentiviral Activation Particles (h2) | sc-418663-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |